BioMarin Pharmaceutical Inc. (0HNC.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.38B |
| Enterprise Value | 10.71B |
| P/E Ratio | -634.78 |
| PEG Ratio | 6.14 |
| Price/Sales Ratio | 3.03 |
| Price/Book Ratio | 1.77 |
| Enterprise/Revenue | 3.97 |
| Enterprise/EBITDA | 32.61 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -0.01 |
| Operating Margin | 0.07 |
AD
Management Effectiveness
| Return On Assets | -0 |
| Return On Equity | -0 |
Income Statement
| Revenue | 3.22B |
| Revenue/Share | 18.88 |
| Gross Profit | 2.48B |
| EBITDA | 613.03M |
| Net Income | 348.9M |
| Diluted EPS | 1.8 |
Balance Sheet
| Total Cash | 736.01M |
| Total Cash/Share | 3.8 |
| Total Debt | 4.17B |
| Total Debt/Equity | 0.67 |
| Current Ratio | 2.44 |
| Book Value Per Share | 32.32 |
Price History
| 52-Week Change | 5.02 |
| 52-Week High | 70.85 |
| 52-Week Low | 49.39 |
| Moving Average 50 Days | 59.42 |
| Moving Average 200 Days | 58.47 |
Statistics
| Average Volume | 1,305 |
| Shares Outstanding | 178.06M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
